European Association of Establishments for Veterinary Education Association Europenne des Etablissem

1
European Association of Establishmentsfor
Veterinary EducationAssociation Européenne
desEtablissements d'Enseignement Vétérinaire
Constitutive Assembly of 27th May, 1988, at the
National Veterinary School of Alfort

• Article 3 - The objective of the Association
  shall be to promote and develop veterinary
  education. It shall reinforce, particularly in
  Europe, co-operation between Establishments for
  Higher Education in Veterinary Science and other
  relevant bodies. It should also act as a Forum
  for the discussions of matters of Veterinary
  Education, in order to improve and harmonize
  veterinary education among the members. It will
  manage the European System of Evaluation of
  Veterinary Training, based on the mandate given
  by the Commission of the European Community
  01-02-1994.

Faculty of Veterinary Medicine
2
Main Objective of the Dutch Veterinary Curriculum

• To deliver a veterinarian who is
• - equipped with adequate clinical skills to work
  on a high-quality level in a specific part of the
  veterinary profession
• starting competence for specific species or
  sector

3
WHAT IS EVIDENCE-BASED MEDICINE?
The EBVM definition by Cockcroft and Holmes, a
process of lifelong, self-directed problem based
learning, the philosophy remains the same -EBVM
is using the best available evidence and your
clinical expertise to make the best clinical
decisions or your patients and clients. Ideally,
clinical decisions incorporate equal proportions
of evidence, clinical expertise, and patient
needs or client preferences. In reality, however,
as clinicians, we may often weigh each of these
important areas differently for each best
clinical decision. Peggy L. Schidt 2007
Veterinary Clinics of North AmericaSmall Animal
Practice 37, 409-616
4
Utrecht University Website

• In 2007 Utrecht University again confirmed its
  position as a leading international research
  university. In the recently published Academic
  Ranking of World Universities by the Shanghai
  Jiao Tong University for Higher Education,
  Utrecht University was rated no. 42 in the world,
  no. 3 in mainland Europe and no. 1 in the
  Netherlands. Utrecht University is seeking to
  enter into new research partnerships and
  participates in both nationally and
  internationally recognised research programmes.
• Utrecht University maintains close relationships
  with business and industry, government
  authorities, interest groups and other
  organisations through contract research and
  consultancy. By developing and intensifying
  collaborative links between the University and
  its partners, the University demonstrates its
  added value to the knowledge society.

5
European Technology Platforms

• Strengthen European research and innovation and
  ensure European competiveness.
• Articulate coherent long term research policies
  representing a consensus between all
  stakeholders.
• Mobilise a critical mass of European, national
  and regional resources
• comprising both public and private financing.

6
European Technology Platform for Global Animal
Health ETPGAH

• Protect Europe from the incursion of epidemic
  animal diseases and zoonoses.
• Deal rapidly and effectively with outbreaks in
  Europe should they occur.
• Assist in speed of access to market,
  facilitation of world trade and the alleviation
  of poverty by reducing the impact of these
  diseases in developing countries.
• Reduce worldwide levels of disease and thereby
  indirectly protect Europe from disease spread by
  people or trade.

7
ETPGAH Stakeholders Groupings

• European Associations relevant to Animal Health
  and Welfare and Food
• IFAH-Europe, COPA-COGECA farming industry,
  EuropaBio, Diagnostics, FVE Veterinary
  Profession, Eurogroup for Animals
• International Organizations relevant to Animal
  Health and Welfare and Food research
  Organizations OIE, FAO, WHO, ILRI, GALVmed
• European Regulatory Authorities Heads of
  Medicine Agencies, EMEA, EDQM
• Representatives from the European research
  Community Universities-EAEVE, Institutes,
  Network of Reference Laboratories
• Member State Representations CVOs, Mirror
  Groups
• European Institutions EFSA, European Commission
  DG Research, DG SANCO, DG Development, DG
  Enterprise

8
(No Transcript)
9
(No Transcript)
10
Recommendations Categories of Strategic Research
Agenda

• Prioritisation of Animal Disease/Infections
• Gap Analysis
• Fundamental Research
• Enabling factors - Quality Assurance
• - Intellectual Property Rights
• - Overcoming Barriers to Technology Transfer
• - Network and Centres of Excellence
• - Education and Training
• - Infrastructure
• Regulatory and Societal - Regulatory Issues
• Issues - Diagnostic tests
• - Societal Acceptance of Technology
• - Community Animal Health Policy
• Global Perspectives

11
(No Transcript)
12
Collaboration on basis of ETPGAH platform and
setting the research agendaby coherence,
innovation, valorisation

• Optimize innovation on well-known pathogens
• Screening and identification of emerging
  pathogens
• Immunology of emerging pathogens/disease
• Safe and effective adjuvants
• Animal model development
• Development of safe and effective antigens
• Economic large scale production

13
Major factors for new disease emergence

• Global climate change
• Human demographics
• International travel and commerce
• Poverty/social inequality

14
(No Transcript)
15
Why is animal health vital for human health?

• 60 of human pathogens are zoonotic
• 75 of emerging diseases are zoonotic
• 80 of potential bioterrorist agents are zoonotic
• gt 80 of emerging new human diseases have
  animal reservoirs
• OIE data
• Animal transport is faster than the incubation
• period of main epizootic diseases.

16
(No Transcript)
17
Acknowledgements

• Declan OBrien
• Managing Director IFAH-Europe
• Jim Scudamore, DVM
• Consultant IFAH Europe
• René M.L. Aerts, PhD
• Vice president RD Biologicals
• Intervet Schering-Plough Animal Health
• Rudolf W. van Olden, MD, PhD
• Medical Director, GlaxoSmithKline, The
  Netherlands
• Roger Mahr, DVM, PhD
• Past-president AVMA

18
(No Transcript)